Smkakd meglumine w&m distrkoate s&ion IRenogratiw76), wbkh ccmtatns mkrobubbks measurkg 6.5 modality. coronary arlericgraphy. provides qualitative planar images of the lumen of major coronary arteries. it does not allow direct evaluation of myccardial tissue perfusion (2-l). Ncwcr imaging techniques (pasitron emisston tomog_ raphy and nuclear magnetic resonance imaging) now being developed will incorporate functional and antonic descriptors td facilitate the clinical evaluation of patients with ischemic heart disease (I). In general, myocardial perfusion patterns are anatomically defined by a complex vascular &work. Furthemmre, transmural myacardial perfusion is a&ted by regional stress, status of lhe underlying vascular anatomy and the viability of the cardiac tissue. Currently. Ihe degree of coronary artery stenosis and the analysis of
regional wall motion by slondsrd two-dimensional echowrdiography do not adequately define the status of tissue blood Row and viability. An ideal tecmdque for assessing such perfusion would acquire data in a real time format while not disturbing either intrinsic y~scular flow characteristics or ventricular contramilc state. Experimental and clinical studies suggest tha: contrast echoardiographic techniques may fulfill these criteria (S-27).
Sonication ofmeglumine sodium diatrizoale solution (Renorrafin-761 reoroduciblv creates sable microbubbles with an'average dkneter skilar to that of red blood cells (5.6.2Sl. These microbubbles Row through the microvasculature without occlusion (29,30) and. a&ding to videodensilometric analyses, reflect physiologic myocardial transit times (8,19). Studies of the &'ects of sonicated Renogretin-76 on left ventricular contractility in dogs (14) have shown that the solution ralher than the presence of microbubbles atkts left ventricular function. Similarly, studier (I5,22) in patients receiving intracoronarv iniections of sonicated microbubbles of l&ografin-76 (I:5 to-2 ml) revealed that left ventricular contractile state wes not sianificanily altered by the presence of the sonic&d microbubbles. in addition. initial clinical studies using contrast ecltocardiography in the catheterization laboratory (20) and the operating room (21) have described the safety of injecting small volumes of agitated microbubble solutions into the sonic root or directly into the coronary art&~ to identify regional perfusion defects.
However, as contrdst echocardiography becomes a useful procedure for assessing myocardial perfusion, it becomes necessary to establish references for blood Row distribution patterns in patients free of coronary artery disease. Accordin&, this reQort correlates mvocardial wrfusion determined by~ontrast khocardiograph; with corkary artery anatomy as identified by arteriography in patients without significant coronary stenosis. were excluded from the overall sludy. Of Ihe SO patients ewhmtcd, 18 were identified by efleriography BI having no significant coronary artery disease. These patients were used as a reference group to establish normal contrast perfusion data and constituted the study group for this report. Coronary arteriegraphy. Routine informed consent for cardiac catheterization was obtained and all standard precatheterization procedures were followed. The eatheterizalions were performed utilizing the Seldinger technique with the patient resting on an angiographic cradle. The cineangiograms were reviewed by en experienced angiogmpher using 250% luminal narrowing as the criterion for significant coronary disease. The coronary artery system that gave rise to the posterior descending vessel was considered to he the dominant vessel.
Methods
Two~dilmnsional contrast eehwrdiographic imagtng. The patient was draped on the catheterization table and rotated into the 30' right anterior oblique position. Echocardiographic images were obtained &o& beneath the drapes overlying the patient's chest and recorded on a one-halfinch (2.5 cm) VHS videotape system. The echocardiographic views as well as the number of injections performed for each view, depended on the quality of the two-dimensional echo. cardiographic images and the amount of time allotted for each study. According to our protocol. the ultrasound imaging time was limited to IO to I5 min for each study to avoid unnecessatily pmlonging the catheterization study. Twodimensional echwrdiogmphic images were recorded before and during the inttacoronary injection of sonicated Renografin-76 microbubbles. For each patient study, the ultrasoued control settings were adjusted to obtain the best visual image quality. The settings were not altered during the course of the study. No patient was prescreened for echocardiographic image quality before catheterization.
Cotthpst agent prqmrpUon. Microbubble sobltions used as echocardiographic contrast agents were prepared in a sterile, standardized manner. The titanium horn of a sonicatar unit (model 220 Heat Systems-Ultrasonics) was sterilized by soaking in B Food and Drug Administration-approved cold sterilant solution (Astracid-S). A 10 ml plastic syringe was filled with 8 ml of sterile Renogratin-76 and placed beneath the sonicator hum. The sonicator horn ~8% placed approximately one-halfinch beoeath the surface of the liquid and the enemy was turned on. The svrinae was then lowered from the horn to permit brief con& with the surface of the liquid. thus creating surface agitation. After 30 s, the salution of sonicrded Renogratin-76 appeared franslucent. The opaque, white appearance of the liquid that accompanies prolonged surface r&&on was not present at the end of the ronic.tion pruccdure. The mew mbrabubblc & determined by light micmscopy (51 was IO * 4 and by laser analysis (28) was 4.5 C 2.8 pm (Fig. I) . Immediately after the energy was turned off, the syringe Plunger was reinselied and the Kdulion was ready for injection thmugh the anpio.
graphic catheter. A totel of 1.5 to 2 ml of the sonic&cd Rensgrafin-76 solution was manually injected into the right or the left coronary artery and simultaneous two. dimensional echocardiographic imaging was performed.
Visual analysts of contrast perfusion. All observers reviewed the cemrest perfusion studies and two observers determined regional perfusion distribution. A paresternal, Regions I through 10 were labeled in a clockwise monmr as f&ws: anterior. anterolateral, postemlateral. pusterior. inferior, inferoseptal, mid-septal, anteroseptal and the anlerolateral and posteromedial papillary muscles. For regions with echocardiographic "drop out:' or loss of lateral border resolution, no assessment of perfusion was made. In areas supplied by both the lefl and right co..mary arteries, dominance of perfusion was established if >5G% of an area was estimated to be petised from the selective arterial injection. did not have rignikmt coronary artery disease. Four of these I8 patients were excluded from further analysis-three because B parasternal, cross-sectional two-dimensional echocardiosraphic view was not available and one beczxxe the conUas1 effecl was inadequate. (The latter patient was the first subject studied in our promcot and the microbubble solution was diluted before the intracoronary injcctiana.) A right dominant curtmary system was nuted in I2 of the 14 patients without signiticant coronary Avery disease: the remaining 2 patients demonstrated a left dominant system. In several al the patients classified as having a right dominant system, the left circumflex coronary artery suppiied arterial branches to the pOster&tcral sspect of the left ventricle. No patient studied developed complications during or after the catheterization procedure. In patients in whom hemodynamic variables were assessed throughout the contrast ecbocardiograpbic portion ofthe study, only minor, transient aiterations were noted in the heart rate. blocd pressure and electrocardiogram (ECG) during the intracoronary injections. Our findings. previously reported (12-15.25). are consistent with recent clinical data from other laboratories (20-2224.26.27). Contrast eebacardiogspby. The contrast echocardiographic perfusion studies in the I4 patients employed P total of 70 intracomnary injections (I .5 to 2 ml each) of sonicated Renogralin-76. The number of injections per patient ranged from four to eight, and the echocardiographic views obtained per patient varied between one and three. with the parasternst 10"$~.x:S and crorr-secrionnl &WS used in 64 ,O,%> af76 ir+xtionr.
ReStlltS
Of the II regions visually analyzed (IO regions in I4 patients). 3 regions in one patient were considered inadequate for analysis purpoxs. In three patients. no right coronary arted injection of microbubbles was wfumted because of difficulty in attaining a stable catheter position. Accordingly. perfusion characteristics wer: analyzed only for the left coronary injections in those three patients.
Awssment of regknll myocwdiil prfttsii in rienB without si@knt eonmary artery dka.w Wig. 3). Regional perfusion based on videointensity was analyzed in each patient using a two-dimensional echocardiognphic paraster- Right dominant coronary artery systeto (Fig. 4) 8.18,19) . We have previously determmed the effects of sonicated microbubbles on len ventricular contractibty in animals using a sensitive noninvasive index of myocardial function (14). Alterations in contractile state noted in that study were attributed to the particular carrier solution or to the presence of the larger hand-agitated bubble solution and not to the presence of the sonicated micmbubbles of Renografin-76 solution (23). This work receot!y has been expanded into clinical trials (IS). In humans, intracoronary injections of small volumes (1.5 to 2 ml) of sonicated microbubbles in Renugraftn-76 did not adversely effect cootrnctility. This war true even though intracoronary injection of large volumes (7 to 9 otl) of Renogratin-76 transiently depressed wntractile state.
Methndoloeic eotwideratioos. For this initial study of nerfusion in pr&tts at the time of cardiac catheterization; we limited the total echocardiogmphic imaging time to approximately IO to IS min. This was done to avoid unnecessary delays in wrfortning the catheterization procedure. Therefore, we did not attempt to fully characterize the left ventricular myocardiol oerfusion. Our efforts revealed that the parastern~l short-&is view was the most commonly obtained image and, hence. we chose to analyze only that level of perfusion in each patient. Because of the clinical utility ofassersing mywxdial perfusion in conjunction with coronary aogiogrnphy, in subsequent studies we have extended the imaging time to permit more views of the tnyoeardium.
With regard to the image quality and yield of the parosternal short-axis views, contrast echocardiogrnphic techniques offer several advantages over those of standard twodimensional echocardiograms. First, the use of microbubblesenhancesthe signal to noise ratiu;thus thequality ofthe two-dimensional image is improved, permitting clearer idenlidcation of endocardial and epicardial surfaces. Consequently, tneasurements of wall thickness and cavity dimensions are easily txrfomted. The enhanced ultrasound sirnals should complement and promote the use of qusntit%ive two-dimensional echocardiography for the evaluation of left ventricular performa~e (40.41). In addition. the enhanced border identification may facilitate the use of cornputerassisted, automated edge detection algorithms, ulti&ely permitting three-dimensional reconstruction of perfusion wtthin the myocardium.
Second, using contrast echocardiograuhic technisues in conjunction with coronary angiography, it is possible to "target" areas of interest in the myocardium. Suecilicaliy, il a clinical question exists regarding the perfusion distribuiion associated with the left anterior descending artery, the ultraround investigation can be directed to the anteroseptal. anterior and anterolateral regions of the myocardium. By identifying the region of interest we can improve the yield ol clinical information. using cootrast echocardiography nt the time of the cardiac catheteiiration. In future studies. b) devoting more time to ultrasuund imaging in the catheterize. lion laboratory. we could obtain several views of the myo. The nonstandardized manual intracoronarv iniections of contrast agents may have resulted in the.rec&itment of capillary vessels, thus disturbing the native blood flow pattcros within the tiwe. The use of a hyperosmalar, biologically active solution (Reno&ut-76) may alter the autoregulation of the vasculature. In addition, the timing of the injection often extended beyond a single cardiic cycle. Thus, the spatial, temporal heterogenicity of regional flow is likely to he altered (42). In the future, a" ECG-gated, volume-and pressure-controlled mechanical injector may reduce the effects of the injection process oo the native coronary blood Row (43) and the use of newly developed air-filled. albumin microspheres should reduce the variability and biologic activity of the current ultrasound conlra~l agents w-46). Cunclusiuns. This initial study suggests that contrast echocardiowauhv utilizine. sonicated Renoarafin-76 microbubbles is a safe, effic&ous and physiologic means of determining regional myoeardial p&ttsion. Further validalion and testing will be required to determine the clinical ulilily of perfomting contrast echocardiographic studies to as&s tisiue blood kow. With the incr&& clinical use of interventional therapies. the need to demonstrate the sevcrity of coronary artery lesions and their physiologic significance is critical (I). This study suggests that important clinical issues regarding coronary artery anatomy and myocardial perfusion can be addressed in a single setting. Used at the time of cardiac catheterization during coronary angioplasty or cardiac revascularization surgery, contrast echo. cardiography may provide no improved understanding of the physiology of blood flow within the myocardium. Subsequent therapy and management decisions could then be approached in a quantifiable tttnnner, perhaps ultimately resulttrig in improved tnanagement of paticnts with ischemic heart disease.
